Focus On

DLA Piper welcomes three to partnership

Wednesday, January 08, 2020 @ 9:10 AM | By John Chunn


DLA Piper (Canada) LLP announced that Jennifer Arndt, Bentley Gaikis and Rebecca von Rüti have been admitted to the partnership, effective Jan. 1, 2020.

According to the firm’s press release, Arndt has practised in the securities and corporate finance group since joining the firm’s Calgary office in 2005. Her primary focus is on securities, corporate finance, banking law and transactional corporate matters. She has represented TSX and TSXV-listed companies on a broad range of corporate finance, securities, mergers and acquisitions and commercial transactions, including plans of arrangements, public equity and debt offerings, takeover bids, reverse takeovers, stock exchange listings, reorganizations, corporate governance practices, share and asset acquisitions and dispositions, continuous disclosure compliance, general corporate matters and corporate governance. Her clients include companies engaged in oil and gas exploration and production, energy services, mining and technology.

Gaikis joined the firm’s Toronto office in the 2016 Dimock Stratton combination. He practises in all areas of intellectual property litigation with a focus on patent litigation. He has represented clients on all stages of patent disputes including providing opinions, preparing court filings, conducting discoveries, arguing motions and providing representation at trial. Gaikis also has experience pursuing alternative dispute resolution such as mediations and simplified proceedings. The technical subject matter of his expertise includes chemical, biotechnology, pharmaceutical and mechanical patents. 

Von Rüti joined the Vancouver office as an associate in 2009 after articling with the firm. Her practice is concentrated on the defence of class actions (national and cross-border) and individual claims brought against, international pharmaceutical companies of prescription and OTC drugs (including several proposed class proceedings relating to the opioid crisis), medical product manufacturers, international educational publishers, international airlines (baggage fees, cargo and passenger surcharges), specialty chemical and raw material manufacturers, electronic device and components manufacturers, as well as international companies, directors and officers for secondary market misrepresentations. She has experience defending consumer protection claims, false and misleading advertising claims, product liability claims, negligence, conspiracy and other anti-competitive claims. She also defends insured and self-insured clients in multiparty and complex bodily injury claims as well as wrongful death, occupier liability and professional negligence matters.